Nath Bio-Genes (India) Limited

Web: nathbiogenes.com NSE: NATHBIOGEN BSE: 537291 SECTOR: Fast Moving Consumer Goods - Agricultural Food & Other Products | Add Note | View Notes

154 0(0%)

Volume

22k as on 23, Jun

Open

186

High

189

Low

182

Close

153

VWAP

168

52 Week High

204

52 Week Low

126

Viand Research Rating
Quality Score

0/100

Growth Score

63/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

292

No. of Shares

1.9

P/E

8.15

P/B

0.56

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

6.83

ROCE

-

Profit Growth

-

Listing Date

28-Jan-14

Promoter Holding

45.59%

FII Holding

0.22%

DII Holding

0.01%

Price Chart
Price Performance
1 Week0%
1 Month3%
3 Months25%
6 Months12%
1 Year12%
YTD12%
Moving Average
5 Day SMA167
10 Day SMA167
20 Day SMA170
30 Day SMA168
50 Day SMA170
61 Day SMA165
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3180171175183
Resistance 2175170172176
Resistance 1172169170174
Pivot Point166168166168
Support 1163167163165
Support 2158167161159
Support 3154166158157
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1HINDUNILVR4,65,57219732%8%15%26%4749.60.0315059
2ITC3,31,6062642%8%16%37%1749.60.0321018
3NESTLEIND2,71,60314102%7%11%17%7749.60.093499
4VBL1,38,6134103%9%9%17%5549.60.133062
5BRITANNIA1,23,62651323%7%14%16%5649.60.272537
6UNITDSPR1,07,09514722%3%9%13%049.60.051838
7MARICO1,06,4168201%6%6%12%049.60.131813
8TATACONSUM1,00,25610102%8%9%5%6749.60.131547
9GODREJCP89,9138795%19%25%29%5749.60.351861
10DABUR67,8893821%11%25%31%5349.60.111869
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(0.01) 45.59%(4.51) 45.59%(0.01) 41.07%(0.01) 41.05%(0.01) 41.03%(0.01) 41.03%
FIIs(-0.11) 0.22%(0.01) 0.31%(-0.11) 0.32%(0.21) 0.41%(0.01) 0.21%(0.01) 0.19%(0.01) 0.18%(-0.11) 0.21%(-0.11) 0.27%(0.11) 0.32%(0.21) 0.22%(-0.11) 0.07%(0.01) 0.13%(0.11) 0.15%(-0.11) 0.01%(0.01) 0.11%(0.01) 0.07%(0.01) 0.04%(0.01) 0.01%
DIIs(0.01) 0.01%(-0.81) 0.01%(-1.51) 0.76%(-1.71) 2.25%(-0.41) 3.94%(0.01) 4.37%(0.01) 4.37%(0.01) 4.37%(0.01) 4.37%(0.01) 4.37%(-0.31) 4.37%(0.01) 4.62%(0.01) 4.62%(0.01) 4.62%(0.01) 4.62%(-0.21) 4.62%(-2.31) 4.85%(-2.21) 7.17%(0.01) 9.38%
Public54.17%54.08%53.31%51.73%50.24%49.83%49.83%49.80%49.76%49.72%49.81%49.71%49.65%49.62%49.77%54.20%54.02%51.76%49.58%
No. of Shareholders33,03133,55034,12234,20734,91135,05635,42335,83435,13234,26334,36533,50233,96034,74935,47035,48435,61033,92633,272
Quarterly Results
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Sales51.5965.9643.85283.751.9736.8732.19243.8843.0431.7422.57235.2844.9925.321.7320927.21
Sales Growth % (YoY)-0.7%78.9%36.2%16.3%20.8%16.2%42.6%3.7%-4.3%25.4%3.9%12.4%65.3%----
Sales Growth % (QoQ)-21.8%50.4%-84.5%445.9%41%14.5%-86.8%466.6%35.6%40.6%-90.4%423%77.8%16.4%-89.6%668.1%-
Expenses47.1162.3937.74245.4151.5528.8327.38207.3439.1126.0917.58198.2641.0619.6816.9817548.52
Operating Profit4.483.576.1138.290.428.044.8136.543.935.654.9937.023.935.624.7534-21.31
OPM %8.685.4113.9313.50.8121.8114.9414.989.1317.822.1115.738.7422.2121.8616-78.32
Other Income3.634.4243.834.40.480.080.131.362.540.060.120.260.060.20-88.05
Interest4.594.543.663.21.373.92.982.241.072.842.442.761.532.962.7532.47
Depreciation1.030.980.990.981.340.830.830.830.980.760.760.760.990.670.6711.05
Profit before tax2.492.475.4637.942.113.791.0833.63.244.591.8533.621.672.051.5331-112.88
Tax %100.435.2211.721.7429.8630.08-2.780.7419.1416.7818.920.6513.7734.153.9213.07
Net Profit -0.011.64.8237.281.482.651.1133.352.623.821.533.411.431.351.4731-116.33
Net Profit Growth % (QoQ)-100.6%-66.8%-87.1%2418.9%-44.2%138.7%-96.7%1172.9%-31.4%154.7%-95.5%2236.4%5.9%-8.2%-95.3%126.6%-
Net Profit Growth % (YoY)-100.7%-39.6%334.2%11.8%-43.5%-30.6%-26%-0.2%83.2%183%2%7.8%101.2%----
TTM Net Profit43.6945.1846.2342.5238.5939.7340.941.2941.3540.1637.6937.6635.25-82.51-83.86-85.330
EPS in Rs-0.010.842.5419.620.781.390.5817.551.382.020.7917.590.760.710.7716.19-61.21
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
Sales44526824823423010997
Sales Growth %66%8%6%2%-12%-
Expenses3932171981851938982
Operating Profit52515049372015
OPM %12192021161815
Other Income14441-8711
Interest16119101142
Depreciation4433355
Profit before tax46414236-63129
Tax %1055364-1
Net Profit 42394035-67129
Net Profit Growth %7.7%-2.5%14.3%152.2%-658.3%33.3%-
EPS in Rs21.9120.3120.8518.43-35.467.345.75
Dividend Payout %9101011-600
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
Cash from Operating Activity-131875381700
Cash from Investing Activity3-4-27-3-2000
Cash from Financing Activity-4-2-8-2-2200
Net Cash Flow-13113934-2500
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
Equity Capital191919191919191616
Reserves6616616256215915545234130
Borrowings138155123128110105931911
Other Liabilities278180259611601141058263
Total Liabilities109710141026828880793739158120
Fixed Assets2492502502512492442453821
CWIP000000000
Investments666665501
Other Assets84275977057162554349012199
Total Assets109710141026828880793739158120
Delivery

Delivery Data: NATHBIOGEN

#Date
151
13%
171
Value (Cr)Q/T
49
Del
69
Del
0
14-Sep153
0
41780
23-Sep153
0
40760
32-Sep153
0
19760
41-Sep152
0
38710
531-Aug158
0
36680
628-Aug157
0
48700
727-Aug154
0
72910
826-Aug153
0
40790
925-Aug153
0
26710
1024-Aug155
0
20590
1121-Aug153
0
24600
1220-Aug154
0
59860
1319-Aug154
0
42640
1418-Aug155
0
55790
1517-Aug154
0
30750
1614-Aug155
0
44850
1713-Aug155
0
55870
1812-Aug155
0
43850
1911-Aug157
0
48810
2010-Aug156
0
41640
217-Aug158
1
69791
226-Aug161
1
83550
235-Aug165
0
65810
244-Aug165
1
55791
253-Aug159
0
36790
2631-Jul159
0
31810
2730-Jul161
2
49461
2829-Jul160
0
25820
2928-Jul164
0
30870
3027-Jul165
0
27710
3124-Jul161
0
28550
3223-Jul155
0
37670
3322-Jul162
0
23680
3421-Jul165
0
43800
3520-Jul164
0
46680
3617-Jul160
0
38730
3716-Jul159
0
50760
3815-Jul161
0
32710
3914-Jul162
0
30720
4013-Jul165
0
23780
4110-Jul165
0
18730
429-Jul163
0
22660
438-Jul162
0
15670
447-Jul169
0
34610
456-Jul169
0
56870
463-Jul167
0
22770
472-Jul165
0
33780
481-Jul165
0
22630
4930-Jun165
0
23550
5029-Jun165
0
30710
Daily Market Cap
DateTotal Market CapChangeChg %
04-Sep292c82L0.28
03-Sep291c4c1.35
01-Sep295c4c1.17
31-Aug298c5c1.67
26-Aug294c95L0.32
25-Aug293c59L0.20
24-Aug292c65L0.22
21-Aug293c4L0.01
19-Aug293c3c0.90
18-Aug295c17L0.06
17-Aug296c74L0.25
14-Aug295c38L0.13
13-Aug294c2c0.64
12-Aug296c82L0.28
11-Aug297c2c0.59
10-Aug299c00
07-Aug299c9c2.93
06-Aug308c4c1.40
04-Aug312c8c2.69
31-Jul304c5c1.51
30-Jul309c2c0.66
29-Jul311c89L0.29
28-Jul312c3c0.88
27-Jul314c10c3.28
24-Jul304c00
Stock Checklist
Price is above from 52 week high low average: 35%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0